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Abstract: Surface modification of dental implants is a key process in the production of these medical
devices, and especially titanium implants used in the dental practice are commonly subjected to
surface modification processes before their clinical use. A wide range of treatments, such as sand
blasting, acid etching, plasma etching, plasma spray deposition, sputtering deposition and cathodic
arc deposition, have been studied over the years in order to improve the performance of dental
implants. Improving or accelerating the osseointegration process is usually the main goal of these
surface processes, but the improvement of biocompatibility and the prevention of bacterial adhesion
are also of considerable importance. In this review, we report on the research of the recent years
in the field of surface treatments and coatings deposition for the improvement of dental implants
performance, with a main focus on the osseointegration acceleration, the reduction of bacterial
adhesion and the improvement of biocompatibility.
Keywords: dental implants; titanium; surface modification; surface coatings; plasma polymers;
osseointegration; antibacterial; biocompatibility
1. Introduction
The goal of modern dentistry is to restore the patient to normal function, speech, health and
aesthetics. A dental implant is an artificial tooth root that is surgically placed into jaws so as to
hold a replacement tooth (the crown) in place. Modern oral implantology began when Per-Ingvar
Brånemark, while conducting experiments in vivo using intra-bony titanium chambers, discovered the
particular connection this metal was capable of developing within the recipient tissue [1]. The concept
of osseointegration, i.e., a stable and direct bone-implant interlock, was originally exposed in two
fundamental publications [2,3]. Currently, commercially pure titanium and Ti–Al–V alloy have become
the gold standard in implant dentistry, although ceramic materials with the use of zirconium dioxide
and innovative metallic alloys are attracting increasing interest in implantology. The main route
adopted by research and industry to enhance osseointegration has traditionally entailed roughening
techniques [4,5], with good outcomes in terms of bone to implant interlock. Common roughening
techniques—usually subtractive—are based on mechanical (grit blasting), chemical (acid or alkaline
etch), electrochemical (anodization) and physical methods (plasma spray) [6].
The possible role of roughened surfaces in favoring the development or at least the maintenance
of peri-implantitis [7] has, however, recently questioned this approach and prompted the use of
different surfaces, such as machined ones. Additive modification methods have, therefore, acquired
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increasing interest among the scientific community to reduce possible microbial infection of clinically
exposed dental implant surfaces, while preserving the advantages roughness ensures during bone
healing. Furthermore, the ability to modulate surface topography in a more controlled way and, to
some extent, to alter the surface chemistry independently of the microscale has induced research
to new and sophisticated proofs of concepts previously deemed impossible. Multicomponent and
multifunctional nanostructures have become relevant in the field of biomedical materials [8]. Indeed,
the most promising materials for bone regeneration try to reproduce the complex nanostructure of
human tissues.
In this review, we report on the most recent surface modification techniques proposed to improve
the properties of Ti dental implants. The work has been organized in two separate sections. The first
one has been devoted to recapitulate the most recent surface modification methods, divided into
surface treatments, inorganic coatings and organic coatings. The second section outlines the most
recent achievements that the different types of surface modification have been demonstrated to produce
in vivo or in vitro.
2. Surface Modification Methods
In this section, we will review the main methods currently studied for the modification of dental
implant surfaces. The technological processes used to change the physico-chemical properties of
materials surfaces can be divided in two main categories, depending on whether a layer of new
material is applied on the implant surface or if the surface itself is changed by exposing it to physical
or chemical agents, such as sand, gases, plasmas, or wet chemicals. In the former case, the method is
usually called coating deposition, while the latter is referred to as surface treatment. The deposition
of a thin film substitutes the original surface with a new one, with different physical and chemical
characteristics, and an interface is created between the coating and the bulk material. This method
has the advantage that a wider range of surface properties can be obtained, since the film surface
may show characteristics that differ substantially from the ones of the coated substrate. However,
since the thin film is deposited on the original surface, there is always the possibility of its partial or
complete detachment. The modification of a surface by means of physical or chemical agents, without
the deposition of a coating, allows changing several surface properties, such as roughness, morphology
and hydrophilicity; however, the range of effects is more limited compared to the case of coating
deposition. One advantage of these methods, compared to the addictive ones, is that there is no risk of
detachment or delamination, since no material has been added to the surface. In the following, we
will review the most important methods of surface modifications and coating materials that have been
studied in recent years.
2.1. Surface Treatments
A wide range of surface treatments have been tested in order to improve the properties of titanium
implant surfaces, including accelerating the osseointegration, reducing the bacterial adhesion and
protecting from the possible detachment of nanoparticles or ions. Only a few of these processes are
used for the fabrication of commercial implants, while many of them, despite having been subject
to intensive research, have not been commercially applied so far. Surface treatments rely on the
application of different types of physical or chemical agents on the implant surface; these include the
following ones:
‚ sand, glass or ceramic microspheres accelerated toward the surface (sandblasting);
‚ exposition to acid or alkali chemicals (wet etching);
‚ anodization;
‚ exposition to laser radiation;
‚ exposition to electron beams; and
‚ exposition to cold plasmas (plasma etching).
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Sandblasting (also called gridblasting) is one of the most commonly used types of surface
modification processes, thanks to the simplicity, low cost and easiness of application. Microspheres of
diameter in the range 10–540 µm are typically accelerated toward the surface to be treated, using a
compressed air or nitrogen blow. Most used grid materials include corundum (Al2O3) [9,10], silicon
carbide (SiC) [11], titania (TiO2) [12], hydroxyapatite (HA) [13], zirconia (ZrO2) [14], silica (SiO2) [15]
and aluminum powders [15]. The main effect of sandblasting is to change the morphology of the
treated surface, substantially increasing its roughness. The value of this parameter depends on
several factors, including: the type of grid material used, the dimension of the spheres, the energy
and angle when they hit the surface, and the duration of the treatment. Typical values of the Ra
roughness are in the range 0.3–3 µm [15,16] as compared to Ra values lower than 0.1 µm for polished
Ti surfaces [15,16]. A side effect of the sandblasting process is the contamination of the surface by the
material released by the microspheres during their interaction with the surface. A recent study [15]
has evidenced how different types of grid materials and microsphere dimensions lead to different
amounts of contamination on the surface, as well as different efficiencies in removing the contaminants
already present on the implant. In particular, blasting with Al2O3 has been found to effectively remove
Si contamination from the machined titanium surface, but led to a Al contamination as high as ~15%
when microspheres of 54 µm diameter were used.
Another surface treatment that has been widely tested is the etching of titanium surfaces with
wet chemicals, such as HCl, H2SO4, HNO3 and HF, or combination of these. The main effect of these
acid-etching processes is to modify the implant morphology by producing micro-pits of a few microns
diameter on titanium surfaces [16,17]. These processes are commonly applied after sandblasting, and
the complete process, usually referred to as sandblasting and large grit acid etching (SLA) [18], is often
considered the reference surface treatment to which other ones are compared [12,16–18]. The most
common process involves the use of Al2O3 microspheres of 200–540 µm diameter, followed the etching
with a mixture of HCl and H2SO4 [16]. Typical result of the SLA process consists in the combination of
a macro-roughness, provided by the sandblasting process, and a micro-roughness, provided by the
acid-etching process [19].
Anodization is another process widely studied, which consists in a potentiostatic or galvanostatic
electrochemical oxidation, usually carried out in strong acids, such as H2SO4, H3PO4, HNO3 or
HF [17,20]. As a result of this process, a thick porous layer of titanium oxide is formed on the
implant surface, which substitutes the very thin and compact native oxide layer. It is also possible to
select, to some extent, the phase of the titanium oxide layer among its amorphous, brookite, rutile
and anatase forms [20]. Micro-arc oxidation is a modification of the oxidation process in which the
implant is immersed in an electrolyte solution containing dissolved salts and acts as the anode of an
electric discharge: much higher potential differences are involved with respect to common anodization
processes, giving rise to the formation of a plasma on the metal surface [21].
The treatment of Ti surfaces by electron beams has also been tested [22,23], and has been used
mainly as a pretreatment for the deposition of CaP coatings on Ti [23]. E-beam irradiation on Ti has
been found to reduce the roughness and to improve the nanohardness of the material [22], allowing
for the deposition of smoother CaP layers [23]. Laser treatments have also been studied in order to
improve the properties of Ti surfaces [24–27]. The main effect of laser radiation on metals, such as Ti, is
to produce a localized melting of the material, as a result of the heating produced by the absorption if
the high density radiation. Thanks to the very strong absorption of radiation in the metal, the melting
process involves only a very thin metal layer under the surface, which is quickly recrystallized after
the radiation beam is moved to another portion of the surface, while a TiO2 layer is formed due to the
interaction of solidifying metal with air [24]. Several types of lasers have been used for the modification
of metals, including ruby, Nd:YAG, argon ion, CO2 and excimer lasers [26]; however, Nd:YAG seems
to be the most experimented laser for the modification of Ti and its alloys for dental implants [24–27].
Typical values of the process parameters are scanning speeds of 100–300 mm¨s´1, pulse duration of
10–20 ns and pulse energy in the range 0.2–0.5 mJ [25]. The morphology of laser-treated Ti is usually
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characterized by an increased roughness compared to machined Ti surfaces, with typical Ra values of
0.5–2 µm [26,27].
The application of cold plasmas to the Ti dental implant surface has also been studied in recent
years. In fact, plasma treatments show many advantages compared to wet techniques, such as
acid-etching, including the absence of chemical residuals on the surface, the avoidance of chemical
waste and the reduced safety concerns during manufacturing [28]. Plasma treatments can be divided in
vacuum plasma treatments (also called reduced pressure plasma treatments) and atmospheric pressure
plasma treatments (APP), depending on whether they are carried out in a vacuum vessel at a pressure
lower than the atmospheric one, or at atmospheric pressure. The main advantage of reduced pressure
plasma is that a lower power is required to activate a plasma discharge at low pressure, allowing for
the use of cheaper and simpler power generators. Moreover, these processes allow a better control
of the plasma environment, avoiding contamination by the external atmosphere, and a wider range
of process gases is available. APP treatments, however, are of much simpler use, since they do not
require the use of complex and expensive vacuum systems. Plasma processes are often applied for
cleaning and sterilization of dental implants after other surface treatments have been carried out,
but they have also been tested for the acceleration of osseointegration [28–31] and the application
of antibacterial properties to implants [28,29,32]. Argon and oxygen are the most used gases for
these applications [28–33]. Plasma treatments also include plasma immersion ion implantation (PIII)
processes, where plasma is used to produce ions, which are accelerated towards the surface of the
treated sample and are implanted into it [33]. Plasma nitriding processes have also been tested [34],
where the plasma produces nitrogen radicals that reach the Ti surface and react with it forming a
TiN layer.
Some surface treatments have also been proposed in order to incorporate some specific chemical
elements on the surface of Ti implants. More specifically, the incorporation of strontium (Sr) on the
surface of titanium implants has been proposed in order to accelerate the osseointegration process.
Modification of Ti surfaces to incorporate Sr ions has been achieved by means of chemical treatments
using a strontium acetate solution [35] as well as by means of micro arc oxidation [36].
2.2. Inorganic Functional Coatings
In this section, we will review the main types of inorganic functional coatings that have been
studied in recent years to improve osseointegration, to enhance biocompatibility or to reduce bacterial
adhesion on Ti implants. Among the most studied coating materials for the enhancement of dental
implants osseointegration are calcium phosphate (CaP) based alloys [37,38], including hydroxyapatite
(HA, Ca10(PO4)6(OH)2) [37] and calcium phosphate cements (CPC) [38]. HA coatings can be deposited
on dental implants by a variety of techniques, including radio-frequency magnetron sputtering, plasma
spray (PS), pulsed laser deposition (PLD) and ion beam assisted deposition (IBAD) [37]. Magnetron
sputtering and IBAD techniques are more suitable to obtain compact films with a smooth surface, and
are usually able to reproduce quite well the morphology of the implant surface if this was modified
before the deposition, e.g., by a SLA process. However, the deposition is slow and the film thickness
is usually limited to a few micrometers [37]. Coatings deposited by PLD or PS are characterized
by their own roughness, and will result in a rough surface even if the surface of the coated implant
was originally very smooth. PS coatings typically show a low density and a high porosity, while
PLD coatings are denser, with the surface roughness mainly due to the presence of micrometric
droplets on the surface [37]. Calcium phosphate cements are usually formed by the reaction between
calcium and phosphate powders in an aqueous phase, leading to the precipitation of CaP [38]. When
in contact with the body fluids, these materials lead to the formation of HA nanocrystals. Several
methods have been tested for the deposition of CaP coating on Ti implants, including PS, sputtering,
sol-gel deposition, and electrophoretic deposition processes, but PS is considered the most successful
so far [28]. Strontium-containing HA coatings, grown by PLD or sol gel methods, have also been
proposed in order to improve the osseointegration process [39,40].
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Titanium oxide (TiO2) has also been tested as a functional coating for the improvement of Ti
implants performance. While the surface of Ti is naturally covered by a thin native oxide layer that is
readily formed as the metal surface is exposed to air, its very low thickness prevents the activation
of important biological effects. Moreover, its structure is usually amorphous, while some of the
most important biological effects, such as antibacterial properties, have been observed especially on
crystalline TiO2 [20]. The deposition of TiO2 thin-films on dental implants is a way to improve
the surface biological properties by controlling the structure, morphology and thickness of the
TiO2 layer exposed to the peri-implant tissues [41–45]. The deposition of TiO2 coatings with the
incorporation of Ag nanoparticles has also been tested [45], in order to imbue dental implants with
antibacterial properties. Several techniques, including magnetron sputtering [41,45], low pressure
chemical vapor deposition (LPCVD) [42], metal-organic chemical vapor deposition (MOCVD) [43]
and plasma spray [44] were used to achieve the deposition of the titanium oxide for improving
osseointegration [42,44] or prevent bacterial adhesion [41,45]. Other oxides, such as ZrO2 [41],
SiOx [46–49] and ZnO [50], have also been tested as alternatives to TiO2 to improve the properties
of dental implants, reduce the bacterial adhesion [41,46,49,50], improve the biocompatibility [47] or
protect from the corrosion exerted by the body fluids [48]. In addition, Zn-doped TiO2 has been
tested as a possible candidate for bacterial adhesion reduction [50]. This oxides are usually grown
by sputtering [41,48], plasma enhanced chemical vapor deposition (PECVD) [46,47,49] or cathodic
arc deposition [50], since these techniques allow the deposition of compact layers and allow a good
coating adhesion even at low temperature.
Nitride coatings have also been tested as candidates to improve dental implants properties,
including TiN [51,52], AlN [48], TaN [53] and Cu- or Ag-doped TiN and TaN [54,55] grown by
magnetron sputtering [52,53,55], possibly combined with plasma nitriding [54]. These coatings have
been intended mainly to improve the osseointegration [51] the protection against corrosion [48,52–54],
and to reduce bacterial adhesion [51,53–55]. In addition, ZrN and ZrCN coatings grown by cathodic
arc deposition [56] were tested against their antibacterial properties.
Moreover, Sr-doped brushite coatings grown by electrochemical deposition methods [57] have
also been proposed recently as a titanium surface treatment for the acceleration of osseointegration.
2.3. Organic Coatings
Various types of organic coatings, polymers (e.g., obtained by plasma discharge) and biomimetic
and bioinspired films (e.g., components of the natural cell surroundings) have been explored on
biomaterials used for dental implants and orthopedic joint prostheses in order to: get an intimate
bone–implant contact, promote osseointegration by proliferation of osteoblasts, prevent for bacterial
adhesion or to impart a bactericidal effect to the implant surface.
In this section, a focus will be reported on plasma polymers both used for the direct
contact with cells involved in osteogenic process and applied as intermediated layers for the
immobilization of several organic species, all enhancing bone repair and osseointegration: Cell
Adhesion Molecules (CAMs), cell stimulating molecules and extracellular matrix proteins (ECMs)
(e.g., glycans, Poly-aminoacids, collagens, pectin, fibrinogen, laminin, osteopontin, insulin, cytokines,
fatty acids, sugars, etc.).
Plasma polymer deposition is a well suited technique for the preparation of a defined interface
thin layer, e.g., at cell culture plates or at bone-implants, for the covalent or electrostatic immobilization
of biologically active molecules aimed to improve the osseointegration (for instance, through an
enhanced bone-titanium interface and better soft tissue integration). In the last years, particular
attention was devoted to the effect of biochemistry occurring at the interface on initial cellular adhesion
and differentiation.
In plasma polymerization, the transformation of low-molecular-weight molecules (monomers)
into high-molecular-weight molecules (polymers) occurs with the assistance of energetic plasma species
such as electrons, ions and radicals. In many cases, polymers obtained by plasma polymerization
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have different chemical compositions as well as chemical and physical properties from those formed
by conventional liquid phase polymerization, even if the same monomers are used. This uniqueness
results from the reaction mechanism of the polymer-forming process.
Bioactive plasma polymeric films have to fulfill essential requirements, which are important for
a subsequent use such as homogeneity, film stability, and adequate type and densities of functional
groups or surface charge. They should be adjustable by the choice of adapted plasma process conditions.
Different precursors and plasma excitation methods, process parameters and reactor geometries
influence the plasma polymerization process and lead to a diversity of plasma-chemical reactions and
thus to different film properties [58]. The low pressure plasma processes are the most widely used:
microwave (2.45 GHz) [59] or capacitively coupled radio frequency (13.56 MHz) [59–65] activated [60],
in planar parallel electrode plates geometry [63–65], in steel chamber [59,63–66] or glass tubes [62,67,68]
reactors, applying a continuous [61,67] or pulsed plasma discharge [59,63–65,69].
In particular, the most exploited functional groups in bioactive plasma polymers are:
‚ –NH2/–CONH2 (amino/amide groups) [59–62,66,69–72];
‚ –COOH/–CHO (carboxylic/aldehydic groups) [63–67,69,73,74]; and
‚ –OH (alcoholic groups) [66,68,72,75].
The plasma polymerization of amine-based monomers is an efficient way to prepare bioactive thin
film polymers terminated with nitrogen containing functional groups. These surfaces are characterized
by a positive surface charge in aqueous environments and thus prone to interaction, especially with
hyaluronan, a negatively charged substance of the extracellular matrix, playing a key role in the initial
adhesion of osteoblasts to artificial surfaces.
If the precursor contains in the chemical structure C=C double bonds, the combination of plasma
and conventional free-radical polymerization is enhanced. For C–C single bonds containing molecules,
the only polymerization mechanism possible is the plasma activation. Finke et al. started from [59]
allylamine (AAm) and ethylenediamine (EDA) to get NH2 terminated Plasma Polyallylamine (PPAAm)
and Plasma Polyethylenediamine (PPEDA) on polished titanium alloy substrates (Ti–6Al–4V_P discs)
by microwave or radio frequency activated plasma discharges, respectively. In the first case, a
microwave (2.45 GHz) plasma reactor was used. After a cleaning/etching step of a continuous wave
(cw) O2 plasma, the polymerization of AAm occurred on the surface of the substrates, placed in a
downstream position, through the application of a MW excited, pulsed, plasma discharge. In the
second case, the deposition was carried out in a stainless steel grounded chamber equipped with planar
electrodes, using a pulsed RF-generator (13.56 MHz). The RF-electrode was temperature-controlled
(10–15 ˝C) to ensure constant temperature of the samples and to set the growth rate of polymerized
EDA to 0.4 nm/s at steady state plasma conditions.
After 1:1 derivatization of R-NH2 by 4-trifluoromethyl-benzaldehyde (TFBA), from the XPS
elemental ratio F/C, the resulting PPAAm is characterized by an amino groups density lower than
PPEDA, even if the aging degradation is lower for the first.
A third coating, obtained by 13.56 MHz RF magnetron sputtering of nylon 6.6 under N2/H2 1:1
gas mixture (PSN), was compared to the previous ones. Even if PSN shows a higher density of amines,
FTIR characterization revealed a high content of nitriles and amide species and a structure that is not
dominated by a hydrocarbon network. Notwithstanding the differences in chemical features, PPAAm,
PPEDA and PSN coatings suffer an oxidation effect due to air aging, resulting in the conversion of
primary amine to acid amides.
The PPEDA coating for corundum blasted titanium alloy (Ti-6Al-4V) applied in orthopedic
surgery [60] can be also obtained by low pressure capacitively coupled radio-frequency (RF) plasma at
13.56 MHz, in the same conditions described in [59], where the processing gas is a mixture of the carrier
gas argon and the vapors of the liquid EDA precursor stored in a vessel, held at a temperature of
about 30 ˝C to ensure a constant vapor pressure. Immediately after the deposition, the coated samples
were stored under ambient conditions in plastic boxes and subjected to an additional sterilization by
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γ´irradiation. Subsequently, the thin films aging and its influence on the cell adhesion were tested on
independent samples after different storage times up to 360 days.
The film aging was in-depth studied by attenuated total reflection Fourier transform infrared
(ATR-FTIR) spectroscopy by monitoring the evolution versus aging time of specific vibrational
absorption peaks: stretching modes of C=N and C”N double and triple bonds, C”C triple bonds,
C=O and O–H bonds. The post-deposition oxidation under ambient air storage is a very quick reaction.
About 60% of the primary amino groups in PPEDA are converted into acid amides and (partially)
imides in the first 30 days of storage on air [59]. Finally, acid amides can be hydrolyzed to carboxylic
acid groups and ammonia. In addition, nitrile hydrolyzes to the same end products.
The N-rich plasma coatings such as PPAAm [61] were deposited, on anodically oxidized Ti
surfaces, also to immobilize hyaluronic acid (HyA), a glycosaminoglycan (ECM substance) that
plays an important role in adhesion, migration and proliferation of osteoblast-like cell (MC3T3-E1
ATCC CRL-2593, a clonal pre-osteoblastic cell line derived from newborn mouse calvaria). HyA is
negatively charged due to the carboxyl group of glucuronic acid. Therefore, it can interact, on one
side, with the aminated and positively charged (–NH2 protonation occurs in aqueous solutions at
physiological pH) PPAAm surface, and, on the other side, it can boost the first contact of the cell
to the surface until the cell synthesizes matrix proteins to mediate the fundamental integrin contact
in focal adhesion migration and proliferation. PPAAm was obtained by a RF generated plasma
discharge, first pretreating the surface in O2, and then, in presence of the AA vapors. The formed
NH2-terminated films was made to react with –COOH termination of HyA by a crosslinking activating
agent EDC (1-ethyl-3-(3-dimethylamino) propyl carbodiimide)-NHS (N-Hydroxysuccinimide) in
aqueous solution, in order to form a covalent amide based bond, which presence was confirmed by
ATR-FTIR characterization (weak peak near 1700 cm´1 assigned to the carbonyl in amide group).
The surface undergoes (observed by SEM and AFM) significant changes as a result of anodic
oxidation, plasma polymerization and subsequent HyA immobilization (Scheme 1 in [61]). The surface
roughness of anodized Ti/PPAAm/HyA sample increased to give a characteristic hill–valley structure
on the 10 µm scale so promoting cell adhesion.
In the frame of biomimetic surface modifications, PPAAm coating, deposited on titanium
was recently studied with respect to the covalent immobilization of extracellular matrix (ECM)
proteins, such as fibrinogen, collagen, laminin, osteopontin [62] and pectins, which are plant-derived
polysaccharides [70]. The cellular response elicited in human umbilical cord cells (HUVECS) [62]
and human osteoblasts (HOBS) [62,70], was evaluated. Cell adhesion can be influenced selectively
according to the surface modifying ECM protein.
In [62], the deposition of PPAAm occurred in a custom-made plasma reactor. The basic setup
consists of a cylindrical Pyrex glass tube.. The alternating current with radio frequency (13.56 MHz) was
applied over an electrode coiled around the glass tube. The vacuum inside the chamber was generated
by a vacuum pump. To protect it from effluent monomer contamination, a cold trap, cooled with liquid
nitrogen was used. Before admission through the needle valve, allylamine was degassed at least three
times using liquid nitrogen to remove dissolved gas contaminations. To produce reproducible results,
plasma polymer films of a thickness of approximately 160 nm were used. The amino terminated
surface, in this case, were crosslinked to the proteins of interest (fibronectin, collagen, osteopontin, and
laminin) by means of a PBS solution of, x-bis-N-hydroxysuccinimide polyethylene glycol (Di-NHS
linker), as shown in Figure 1 in [62]. After the surface activation by the Di-NHS linker, the proteins
were immobilized by placing the samples with the upside on a 30-µL droplet of each solution for 1 h.
After rinsing with PBS, samples were carefully dried under an air stream. All the process flow was
characterized in terms of kinetics of adsorption by SPR measurements, using, as deposition substrates
for PPAAm, gold slides. Low adsorption efficiency was observed only for osteopontin. One possible
explanation is the low concentration of the solution used for the osteopontin immobilization and its
small size, in the range between 44 and 75 kDa, which produces a low perturbation of SPR signal, in
terms of refractive index change.
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Pectin Rhamnogalacturonan-Is (RG-Is), isolated from potato and apple [70], was covalently
immobilized on the PPAAm coating deposited on Ti discs, placed on a water cooled grounded
electrode of an RF (13.56 MHz) plasma reactor, according to the following process parameters: a
deposition time of 30 s with a discharge power of 100 W and pulsed plasma with a duty cycle of 4 ms
on and 4 ms off. The RG-Is was covalently coupled via reaction between its carboxyl groups and
the primary amino groups on the surface of the aminated Ti discs. EDC/sulpho-NHS was used as
coupling agent. If RG-Is contains a high amount of galactose, it is able to increase mineralized matrix
formation of osteoblastic cells in vitro.
Schröder and Finke [69] also explored the plasma polymers obtained by acrylic acid (PPAAc) in
comparison with PPAAm, coming from allylamine, in terms of capability to influence the adhesion of
human mesenchymal stem cells (hMSCs) and inflammation processes on titanium substrates, which
are representative of real implant surfaces. While carboxyls (from PPAAc) lead to negative surface
charges, amines (from PPAAm) are strongly basic at biological pH of 7.5, leading to positive surface
charges. The effect of the negatively and positively charged chemical functional groups introduced by
plasma polymerization on the adhering cells was studied.
PPAAc is often obtained by RF plasmas with a high density of carboxylic groups. The setting of
discharge parameters is crucial in order to get a film stable and insoluble in water. This goal could be
achieved through a high degree of cross-linking, but the consequent chains high fragmentation at high
discharge power determinates a strong decrease of –COOH groups density. Notwithstanding, it was
demonstrated that a finely tuned pulsed RF plasma discharge allows obtaining a high surface density
of carboxylic groups (1015–1016 –COOH/cm2), stable in aqueous solutions, able to covalently graft NH2
terminated c-DNA probes, complementary to Listeria monocytogenes oligonucleotides, for microarray
diagnostics [63] and proteins (Protein A) if deposited on porous silicon matrices [64]. Moreover, when
applied to polypropylene hernia-repair meshes [65], PPAAc can be successfully loaded with silver
nanoparticles that were shown to be moderately released in physiological media. Two different actions
can so be exploited: (i) immediately after the surgical operation, the silver released in solution can
exert the antimicrobial action in the aqueous environment nearby the surgical site; and (ii) the silver,
remained at the biomedical device surface, can reduce the formation and/or the adhesion of bacteria
biofilms onto the prostheses interface.
In [69], PPAAc was deposited on polished Ti discs (TiP) by applying a microwave activated
plasma discharge (reactor described in [59]), and using pulsed discharges with different “plasma
on” times and duty cycles (DC). A liquid handling system allowed exact dosing of the precursors,
by a calibrated needle valve. The films, whose thickness was about 50 nm, characterized by X-ray
photoelectron spectroscopy (XPS) and ATR-FTIR, showed high content of carboxylic groups. PPAAm
was also deposited on TiP by the same apparatus with a different DC. The comparison in terms of
stability of the different chemical groups (percentages of bonding components in C1s peak, by XPS),
shown in Figure 2 in [69], after 10 min sonication in water, confirmed the reliability of the films in
aqueous media. The Z-potential characterization was able to widely discriminate the opposite charged
surface of the two kind of coatings.
Plasma co-polymerization [67] of a mixture of acrylic acid and ethylene allowed to combine in
the resulting PPEthAAc film the advantages of each precursor, the first characterized by a functional
group, such as acrylic acid (–COOH), and the second acting as a chain extender or cross-linker.
The films were grown in RF (13.56 MHz) glow discharges in a tubular glass plasma reactor
equipped with two parallel internal and symmetric stainless steel electrode plates. The upper electrode,
shielded, is connected to a RF generator through a matching network; the lower, substrate holder, is
grounded. Argon was used as carrier gas for acrylic acid vapors and ethylene gas and to sustain the
plasma discharge. Different experimental conditions were used to tune the surface density/distribution
of functional carboxyl groups and to obtain substrate-adherent coatings, stable in water. The presence
of ethylene goes to influence this last goal. The films were deposited on c-Si for the XPS characterization
and water stability tests. PTFE disk were used as substrates for the estimation of the density of –COOH
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group by Toluidine Blue-O (TBO) colorimetric titration before and after water soaking. Preliminary
biological in vitro experiments in Polystyrene (PS) Petri dishes coated with a PPEthAAc film were
used as substrates for a preliminary cell culture experiment with Saos-2 osteoblast cell lines. The best
quality film was obtained by a fixed ratio of ΦEth/ΦAA = 3, with RF power values of 30, 50 and 80 W.
In particular, the 30 W-obtained coating shows a highly good stability, after immersion in water of the
exposed –COOH groups. This result would have been very hard to reach if only AA had been used as
feed, at low RF power. Ethylene does not contribute to the coatings with oxygen containing groups but
introduces cross-links in the network, thus discouraging interactions between PPEthAAc and water
and reducing film solubility. TBO data show that the density of –COOH groups in PPEthAAc coatings
decreases when the RF power is increased (7 ˆ 10´6 mol/cm2 after water soaking). Concerning cell
adhesion, osteoblasts grew on 30 W PPEthAAc surfaces even better with respect to the bare Petri
control, as proved by the higher number of adhering cells.
PPAAc was successfully deposited [73] on the surface of biodegradable polycaprolactone (PCL)
scaffolds in order to immobilize the recombinant human bone formation protein-2 (rhBMP-2), a class of
locally signaling molecules that promote bone formation by both osteoconduction and osteoinduction,
so producing a substrate that can replace bone tissue for a long period owing to the low biodegradation
rate. The plasma process was carried out by using a capacitively coupled RF plasma polymerization
system [66], consisting in a vertically placed stainless steel cylindrical chamber. The RF electrode
is placed horizontally at the center of the chamber and connected to an RF (13.56 MHz) source and
the ground steel electrode holds the substrate to be processed. An oxygen plasma pretreatment was
conducted to decontaminate and activate the sample surface. Acrylic acid monomer was evaporated
at room temperature (32 ˝C in a water bath) from a container and its vapor was introduced into the
vacuum chamber. In addition, in this case, the quantification of the –COOH surface density was done
by TBO colorimetric titration (on 2 cm diameter titanium discs that are inert towards the chemical
procedure), evidencing that the density of carboxyl groups decreased with increasing plasma discharge
power. At a plasma discharge power of 60 W, the density of carboxyl groups was 0.04 mmol/cm2,
ensuring a moderate wettability that promotes the adsorption of an appropriate amount of proteins
and thus the adhesion of cells. Moreover, the obtained 85 nm coating is quite stable in water. Finally,
after incubation of rhBMP-2 proteins, the ATR-FTIR characterization showed that the peaks of the
bonds related to the amide moieties of the protein is present, so confirming that rhBMP-2 is adsorbed
on the functionalized PCL scaffolds.
In addition to Poly ε-caprolactone (PCL), poly D,L-lactic acid (PDDLLA) scaffolds, with
controlled pore dimensions (100–200 µm), were used as substrates of deposition of plasma polymers.
In particular [71], low pressure RF (13.56 MHz) Glow Discharges were applied in presence of
ethylene/N2 mixtures (for PCL) and allylamine (for PDDLLA) to get N-containing species penetration
inside the core regions of scaffolds. The obtained cell adhesive coatings are shown to increase the
affinity of Saos2 osteoblast and 3T3 fibroblast cell lines, respectively.
PCL scaffolds were modified in a C2H4/N2 mixture (1:3), in continuous mode (a stainless steel
parallel plate plasma reactor was used), obtaining a N-containing plasma polymerized ethylene (PPE:N)
film, whose thickness on flat PCL substrates was 500 nm. Then the scaffolds were plasma treated in H2
in order to impart a different surface chemical composition to the scaffold periphery e.g., rich in –NH2
groups (short H2 plasma treatment time) or rich in hydrocarbon moieties (long H2 plasma treatment
time). PDDLLA scaffolds (a glass reactor, equipped with two external, capacitively coupled electrodes,
was used) were first cleaned with an O2 plasma etching and then coated in pulsing power mode, with
a plasma-polymerized allylamine coating (PPAAm), whose thickness on flat PDDLLA surfaces was
100 nm. A further film, 20 nm thick on flat surfaces, was then plasma deposited in continuous power
mode from hexane vapors, thus obtaining a plasma polymerized hexane (PPHex film).
This new double deposition process from allyl amine (core) and hexane (periphery), created a
chemical gradient from the top to the bottom of the scaffolds, that increased the metabolic activity of
cells inside the scaffolds. Therefore, by homogeneously decorating the scaffolds with a cell-adhesive
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PPAAm film and a cell-repulsive thin PPHex barrier only on the outer surface, cells are forced to faster
colonize the core of the scaffold.
Some authors [66,72] compared the PPAAm and PPAAc coating with the one obtained starting
from allylalcohol (PPAAl) on 2 different kind of substrates: SLA-treated titanium (Ti) surfaces [72] and
magnesium (Mg) discs [66], as screws and plates made of Mg alloys provide stable implant materials
that degraded in vivo, eliminating the need for a second operation and promoting osseointegration with
an increased bone mass around the Mg alloys. In both cases, a capacitively coupled radio frequency
(13.56 MHz) discharge plasma device was used for films deposition. Beyond all described low pressure
plasma technique, [74] non equilibrium atmospheric pressure plasma processes, in particular based on
dielectric barrier discharges (DBDs) mechanism, can be applied in the frame of deposition of plasma
polymers on biomaterials. Starting from the aerosol of the organic precursor, the plasma system
reported in Figure 1 in [74] was used to deposit –CHO containing coatings from lactic acid (PPLA)
and tetraethylene glycol dimethyl ether (PEO-like) of possible interest in biomedical applications as
biodegradable and non-fouling polymers, respectively. For the first coating, a water DL lactic acid
(LA) solution 90% v/v was atomized with N2 or He by using a constant output atomizer. The DBD
deposition system includes two parallel plate electrodes each covered with a 3 mm dielectric glass plate.
N2 or He were used as carrier gas, the LA aerosol was generated by means of a constant flow of N2 or
He. The LA aerosol mixed with N2 or He carrier was fed at one-end of the inter-electrode gap (tunable
according the process requirements). Deposition time (10 min) and applied frequency (4 kHz) were kept
constant. For the second coating, liquid tetraethylene glycol dimethyl ether (TEGDME) was atomized
with He and admitted longitudinally the two square parallel plate electrodes located in a Plexiglas
enclosure. Each electrode was covered with a 1.9 mm thick alumina dielectric plate. The TEGDME
aerosol was let in the discharge with a constant He flow rate. From ATR-FTIR characterization, it results
that the PPLA film retains the ester groups, important for applications where the (bio)degradation of
the material is required, since these groups are directly involved in the degradation reactions. These
optimal condition are obtained when He is used as buffer gas instead of N2. For PEO-like coatings,
a balance between a high percentage of CH2CH2O– ether groups and a slight cross-linking has to
be achieved in the coating to obtain films with non-fouling properties and good stability in water at
the same time. A crucial parameter seems to be the chemical composition of the feed rather than the
applied power. Thus, decreasing the flow rate at fixed applied Voltage, was found by XPS analysis
a PEO (high density of the CH2CH2–O ether functionalities) character of 70%, comparable to those
deposited at low pressure.
Among antibacterial applications of plasma polymers, a recent and promising study on
terpinen-4-ol [68] was conducted by using a custom-manufactured glass deposition chamber equipped
with copper electrodes capacitively coupled to the reactor so that RF (13.56 MHz) energy is delivered
into the deposition chamber [75]. The resulting plasma polymerized polyterpenol (PPT) films are
able to retard adhesion and proliferation of several human pathogenic bacteria thanks to the exposed
O-containing functional groups that can be tuned by changing the RF power. Improved stability was
observed for films fabricated at higher RF powers due to the increased degree of cross linking and the
decrease in the oxygen content associated with the higher deposition power; the decrease in oxygen
containing functional groups was responsible for the increased hydrophobicity of the polymer surface,
so enhancing its anti-fouling properties.
3. Biological Effects
The present section focuses on the biological effects exerted by surface modifications, especially
additive techniques, suitable for bony interfaces with a particular interest for both organic and inorganic
thin film coatings. For the sake of clarity, a short outline of the most recent research achievements will
be portrayed by subdividing the matter into:
‚ bioactive surface modifications (i.e., releasing signal molecules, ions or drugs), for enhancing bone
quality or with antimicrobial features;
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‚ structural surface modifications (i.e., treatments aiming at reproducing either peculiar features
of the recipient tissue or artificial topographies capable to elicit a biological response), such as
Hydroxyapatite (HA) coatings and nanostructured surface modifications.
3.1. Bioactive Surface Modifications
3.1.1. Enhancing Bone Quality
Strontium (Sr) has been described as a possible therapy to promote bone growth in osteoporotic
patients, as it both increases new bone formation and reduces bone resorption [76]. Interesting attempts
have recently been proposed to functionalize titanium implants with strontium. Micro-arc oxidation,
alkali treatment and ion exchange were used to incorporate Sr [36] so as to attain a Sr-doped Ti surface.
The modified surface remarkably enhanced the adhesion, spreading and osteogenic differentiation of
mesenchymal stem cells in vitro, even when compared to a control chemically and topographically
identical except for Sr content. Sr-doped Ti proved its increased bioactivity in the ovariectomized rat
femur model in vivo, promoting a significant osseointegration.
With a partially similar approach, a hierarchical hybrid micro/nanorough strontium-loaded
titanium surface was fabricated through hydrofluoric acid etching followed by magnetron
sputtering [77]. This surface modification significantly improved the proliferation and differentiation of
osteoblasts compared with a smooth titanium surface, a micro-roughened titanium surface treated with
hydrofluoric acid etching, and a strontium-loaded nano-roughened titanium, which was confirmed
also by the bone to implant contact obtained at 12 weeks in rats and the pullout tests performed. These
data suggest that the enriching titanium surfaces with strontium may be a viable option for clinical use.
Similar effects could be induced by bisphosphonates as reported by Bosco et al. [78] who
functionalized hydroxyapatite nanocrystals with alendronate and demonstrated the inhibitory effects
of the coating on osteoclast-like cells. To conjugate the useful effects of strontium and zoledronate (ZOL)
Combinatorial Matrix-Assisted Pulsed Laser Evaporation (C-MAPLE) was applied to deposit gradient
thin films with variable compositions of Sr-substituted hydroxyapatite and zoledronate modified
hydroxyapatite on titanium substrates [79]. The peculiar composition of the thin films promoted
bone growth and inhibited bone resorption, with a promising synergistic effect in cell cocultures of
osteoblasts and osteoclasts.
Layer by layer apposition has been conveniently described as a possible way to attain coatings
capable of dismissing a range of bioactive molecules. It is the case of Bone morphogenetic protein 2,
a well-known bone inducer introduced into microporous architectures mimicking the extracellular
matrix [80]. In this study, self-assembling polydopamine (PDA) microcapsules, optimal for growth
factor immobilization and release, were coated with polystyrene (PS) microspheres and assembled
using positively charged chitosan (CHI) layers. The produced microporous PDA architectures allowed
the sustained release of BMP-2.
A layer-by-layer adsorption of polyelectrolytes albumin and heparin was proposed for controlled
binding of basic fibroblast growth factor (FGF-2) [81]. Interestingly, the bioactivity of the adsorbed
FGF-2, as assessed in vitro, was more pronounced on surfaces at a lower surface concentration of the
growth factor. Finally, to achieve an even finer control over the peri-implant bone a sophisticated
technology has been proposed based on siRNA nanoparticles embedded in chitosan grown recurring
to the layer by layer technique [82].
3.1.2. Antimicrobial Features
Titania nanotubes engineered by electrochemical anodization process have been proposed to
develop drug-releasing implants in orthopedics and dentistry [83–85] owing to their biocompatibility
(for a complete review, please refer to [83]). As the prolongation of drug release from these
nano-reservoirs is still a challenge, the relation between nanotube dimensions (diameter, length,
aspect ratio and volume) and drug release rate was investigated finding that systems with higher
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aspect ratios released drug slower [84]. Titanium nanotubes could become a feasible technology for
real-life clinical applications. This will imply the implementation of different approaches to overcome
some technical and commercial challenges.
Silver is traditionally a well-known and widely used antibacterial agent. Codoping dental
implants with silver by femtosecond laser doping was proposed, obtaining good results [86]. Likewise,
Silver-sourced plasma immersion ion implantation (Ag-PIII) was used to modify the surface of stainless
steel [87]. In a clever approach, thin film coatings containing a binary Ag-Ti gradient were deposited
generating a gradient of the bioactive ion [88]. It is noteworthy that the structural properties, such as
varied porosity and degree of crystallinity, rather than the amount of incorporated Ag, governed the
Ag` release. The coating also demonstrated in vitro apatite-forming abilities, where structural variety
along the sample was shown to alter the hydrophilic behavior, with the degree of hydroxyapatite
deposition varying accordingly.
Among the numberless techniques already reviewed in the scientific literature concerning drug
releasing systems for preventing the bacterial colonization of intrabony prostheses, the authors wish
to quote two recent studies. Using as a carrier a novel lipid-based material that may be applied as
an implant coating at point of care, antibiotics such as amikacin and vancomycin were loaded and
tested against Staphylococcus aureus (S. aureus) and Pseudomonas aeruginosa [89]. Very promisingly,
antibiotic-loaded coatings reduced attachment of bacteria in vivo, although future evaluations are
needed to include preclinical models to confirm therapeutic efficacy. A versatile method with tailored
drug release profile has been described by Chen et al. [90]. Briefly, an electrophoretic deposition
technique was developed for the fabrication of antibiotic-loaded PHBV microsphere (MS)-alginate
antibacterial coatings. From the qualitative antibacterial tests, MS containing coatings showed excellent
inhibition effects against Escherichia coli (E. coli), suggesting that the proposed technique may be
considered a promising approach for the controlled in situ delivery of drug or other biomolecules.
3.2. Structural Surface Modifications
3.2.1. The Inorganic Bone Matrix: Hydroxyapatite
Calcium phosphate ceramics, such as hydroxyapatite (HA), have been traditionally the first choice
when bone matrix is to be reproduced because of their good biocompatibility and bioactivity [91].
The growing awareness of the major role played by the physico-chemical features of surfaces in ruling
the fate of a biomaterial/host tissue interaction, stimulated an intense research activity aimed at
finding preparation/modification procedures that would result in HA particles exposing surfaces with
optimized properties [92–94]. Relevant advances in the elucidation of HA surface structure-properties
relationships were obtained for micrometric hydroxyapatite particles terminated by defined crystal
planes (calcium hydroxyapatite belongs to the P63/m space group), that exhibited two families of
different binding sites, called C and P sites, respectively [95]. C sites, should act as adsorbing sites for
acidic proteins, whereas P sites are expected to behave as adsorbing sites for basic proteins. Evolution in
the preparation techniques has led to methods for obtaining HA in nanosized forms, mimicking those
naturally occurring in bone [96]. Interestingly, nano-HA exhibited improved in vitro performances in
tests with osteoblasts [97,98]. Structure is also important for biomimetism, as the mineral component
of bone has well defined features in relation to bone tissue function and age [99,100]. In this respect,
the possibility to turn quite smoothly the bulk structure from highly to poorly crystalline or actually
disordered by changing preparation conditions, such as temperature, presence of anionic and/or
cationic substituents, nucleation on collagen fibers, is well known [101]. Still, in recent years, several
studies [102–105] revealed that HA nanoparticles can be coated by an amorphous, non-apatitic surface
layer surrounding a crystalline hydroxyapatite bulk. However, the possibility of obtaining apatitic
particles with crystalline structure extended up to the surface was recently reported [106]. In addition,
HA surface feature may be modified by exchanging part of calcium ions with other divalent cations.
For instance, the presence of Mg2+ resulted in a significant modification of the surface hydration [107].
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Such a behavior is of particular interest because of the widely accepted casual sequence: (i) HA
surface structure; (ii) states of adsorbed water; and (iii) states of adsorbed proteins [108]. These latter
are the actual “biosurface” that interact with cells during the mineralized tissue healing. Therefore,
the possibility to promote the adhesion and proliferation of osteoblasts as well as osteoconductivity
in vivo on HA coated materials has been explored in a great number of papers. Recently, research
seemed to focus particularly on technical optimization of HA coatings. A hybrid nanostructured
hydroxyapatite-chitosan composite scaffold was fabricated and successfully tested on human bone
marrow stem cells and in a rat model [109]. Mineral substituted hydroxyapatite and carbon nanotube
reinforced mineralized hydroxyapatite composite coatings on titanium were prepared by pulsed
electrodeposition. An improved viability of osteoblasts was observed in vitro on the latter coating,
which was also evaluated in vivo in Wistar rats [110]. Using a compound surface treatment of sand
blasting and acid etching followed by hydroxyapatite radio frequency sputtering, Lai et al. assessed
the feasibility of a possibly scalable process. [111].
Through Electrophoretic deposition Farnoush et al. generated functionally graded coatings
of HA/TiO2 nanoparticles and HA-TiO2 nanocomposite coatings with different tenors of
TiO2 on Ti-6Al-4V substrate [112]. While thin radio-frequency magnetron sputter deposited
nano-hydroxyapatite films were formed on a Fe-tricalcium phosphate bioceramic composite,
obtained by conventional powder injection moulding technique [113], amorphous calcium phosphate
nanospheres and hydroxyapatite nanorods were prepared and hybridized with polylactic acid to
fabricate the composite nanofibers through electrospinning [114].
3.2.2. Nanostructured Surface Modifications
A large amount of research has been recently carried out to determine the optimal surface
nanotopography for intrabony applications [115]. Titanium dioxide (TiO2) nanotubes present
numerous advantages as they may be simply obtained by electrochemical anodization or other
processes such as the hydrothermal or sol-gel template. In addition, TiO2 nanotube morphology
is correlated with many mesenchymal cell functions such as adhesion, spreading, growth and
differentiation, which were shown to be maximally induced on smaller diameter nanotubes (15 nm),
but hindered on larger diameter (100 nm) tubes, leading to cell death and apoptosis [115]. Research
has supported the significance of nanotopography (TiO2 nanotube diameter) in cell adhesion
and cell growth, and suggests that the mechanics of focal adhesion formation are similar among
different cell types. To investigate in vitro the effects of surface topography of titanium, a series of
micro/nano hierarchical structures were fabricated onto micro-structured titanium substrates via
a sol-gel method with spin-coat technique, finding that large grains (80 nm) greatly promoted the
proliferation and differentiation of mesenchymal stem cells compared to small grains (20 nm and
40 nm) [116]. In addition, a nanostructured surface was engineered by integrating TiO2 nanorods
into TiO2 nanodot films. The nanorod integration had an obvious influence on pre-osteoblast cell
responses and accelerated cellular osteogenesis. [117]. A thin ribbonlike octacalcium phosphate coating
electrodeposited on a hierarchically structured titania surface showed an improved biomineralization
ability, in comparison to control, when immersed in simulated body fluid and tested on cells
in vitro [118]. Modification with a nanoscale TiO2 coating enhanced the biological response when
compared to the uncoated alloy both in vitro and in vivo. Liu et al. [119] evaluated cytocompatibility
and early osseointegration of an innovative Ti-24 Nb-4 Zr-7.9 Sn surface. According to Anitua and
colleagues [120] based on in vitro and in vivo analyses, titanium implants modified with calcium ions
represented a valuable route to improve osseointegration. Calcium ions, indeed, prevent adventitious
hydrocarbon passivation of the oxide layer and produce a durable chemical and nano-topographical
modification of the titanium oxide interface.
As biomimetic surface modifications are regarded as promising approach to stimulate cellular
behavior at the interface of implant materials [121], plasma based polymerizations methods are
acquiring great relevance owing to their efficiency and efficacy. Among them, freshly prepared
Coatings 2016, 6, 7 14 of 22
amino-terminated films (PPAAm, PPEDA and PSN [59] described in Section 2.3) and deposited on Ti
discs, enabled the Human osteoblasts (MG-63 cells, ATCC) to grow in a very flattened and widespread
phenotype in the initial phase of adhesion (5 to 30 min). However, a direct correlation between the
number of primary amino groups and enhanced cell growth was not found. In fact, not only primary
amino groups but also other N-functional groups, such acid amides or imides, play a role for the initial
cell functions.
As it may concern the behavior of osteoblasts on the PPEDA obtained by a different plasma
process [60] described above (Section 2.3), it was found that the initial cell adhesion after 10 min was
significantly increased by the presence of the coating, without any relation to the storage time of
up to one year. Although the PPEDA thin film was already chemically modified within 0–30 days
after deposition, the cell adhesion was still increased by approximately 55% at day 360. Finally,
the additional sterilization process by γ–irradiation has no influence on the improved cell adhesion
and proliferation.
The cell viability on another kind of PPAAm coating [61] reported in Section 2.3, deposited on
anodically oxidized Ti surfaces and successively derivatized by HyA, was assessed using a direct
mitochondrial activity assay (MTT). The cell adhesion (three days after seeding) of the aminated
sample (anodized Ti/PPAAm) increased to 67% compared to the untreated Ti sample. This indicates
that –NH2 groups on the surface can have some positive effects on the implant cytocompatibility.
In particular, after six days the anodized Ti/PPAAm/HyA surface showed an 80% increase of cell
viability attributed to the improved adhesion and spreading ability of HyA. On the other hand, the
viability of MC3T3-E1 cultured on the anodized Ti and anodized Ti/PPAAm samples showed a
decrease after six days, confirming that hyaluronic acid is required to enhance cell proliferation.
Representative extracellular matrix proteins fibrinogen, collagen, laminin, and osteopontin were
covalently linked to titanium substrates through a PPAAm coating and tested in cell cocultures with
interesting results [62]. The biological response shows a distinctly enhanced cell adhesion and cell
coverage of HUVECS on fibronectin and collagen modified surfaces at all investigation times compared
with the titanium control. For laminin modified surfaces, no cell adhesion is observable as it might be
possible that the used HUVECS do not express the suitable integrin receptors that are able to interact
with laminin. For HOBS, at all investigation times and on all modified surfaces, cell adhesion and cell
coverage was distinctly enhanced compared with the titanium control.
The comparison, as for in vitro cell tests, between a PPAAm and a PPAAc film was focused
by Schröder and Finke [69]. The positively charged PPAAm film improved, considerably, the
spreading of hMSC-, while PPAAc coating reduced the cell area, if compared with bare TiP. Both
the films facilitated osteogenic differentiation, which became evident by increased expression of
osteogenic differentiation-related mRNA. As for in vivo implantation in rats, the PPAAc surfaces
caused significantly stronger reactions by macrophages and antigen-presenting cells compared to
untreated controls, thus suggesting the PPAAm is more suitable for application of regeneration
bone tissue.
In addition, SLA treated Ti surfaces and successively coated by PPAAc, PPAAm and PPAAl
films [72] were tested in vitro with the MC3T3-E1 cells. PAAc (COOH)/SLA and PPAAm (NH2)/SLA
surfaces exhibited more cytoplasmic extensions than on the bare SLA treated Ti and PPAAl(OH)/SLA,
with a preference of proliferation for N-containing plasma films, as already previously reported [69].
Biodegradation tests were also performed on Mg discs covered by the same kind of thin plasma
polymers [66]. The untreated Mg and PPAAl (OH)/Mg samples exhibited obviously immediately
corroded surfaces compared with the other plasma-polymerized samples. In particular, the surface of
untreated Mg showed large pits. The plasma polymerized PPAAc (COOH)/Mg and PPAm(NH2)/Mg
samples revealed slightly corroded surfaces with only a few small pits and a following better behavior
in biodegradation. The plasma-polymerized PPAAc (COOH)/Mg surface was favorable for bonelike
apatite formation compared with untreated Mg and plasma-polymerized PPAm(NH2)/Mg and
PPAAl(OH)/Mg surfaces.
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In addition to nanostructured inorganic substrates, PCL and PDDLLA scaffold were coated with
the plasma polymers described in [71] and discussed in Section 2.3. After 48 h of Saos2 osteoblasts
culture, a higher proliferation of cells on PPE:N/H2 treated PCL scaffolds with respect to the untreated
ones, is observed. On the PPHex/PPAAm coated PDDLLA scaffolds, 3T3 fibroblast cell proliferation
and a slightly higher metabolic activity after 48 h culture time was observed, with respect to the
untreated ones.
Dental implants made of commercially pure titanium are prone to wear and abrasion. Among
the surface modifications aiming at improving abrasion resistance, titanium nitride (TiN) coatings
were successfully proposed [122]. For the same reason, tantalum is gaining considerable attention
for designing a novel type of dental implant, due to its biocompatibility, corrosion resistance and
elastic modulus (1.3–10 GPa) close to that of cortical bone (12–18 GPa). Tantalum promotes bone
ingrowth by establishing osseoincorporation that will enhance the secondary stability of implants in
bone tissue and is more osteoconductive than titanium or cobalt-chromium alloys. [123] Oxidized
Ta-based coatings were deposited by reactive DC magnetron sputtering onto Ti CP substrates in an
Ar + O2 atmosphere [124]. Bioactivity tests demonstrated that highest O-content coating showed an
increased affinity for apatite adhesion, with higher Ca/P ratio formation, when compared to the bare
Ti substrates. Tantalum nitride (TaN) coatings were firstly developed via magnetron sputtering greatly
increasing the hardness and modulus of pristine Ti [53]. Antibacterial and corrosion resistance features
were described and resulted in better performance in comparison to bare Ti and TiN-coated samples.
An interesting research route aiming at reducing bacterial adhesion not based on drug delivery
but rather on the fine modulation of the chemical and topographic characteristics of the interface
is worth noting. Designing implants to control bacterial adhesion entails thorough knowledge of
their surface. Recurring to magnetron sputtering deposition, amorphous and crystalline titanium
oxide and zirconium oxide coatings were produced controlling micro- and nanoscale morphology [41].
The effect of the atomic arrangement or crystallinity was analyzed as for the adhesion of E. coli and
S. aureus. Nano-topography and surface energy were affected by the coating structure: interestingly, at
a sub-micro scale, both the crystalline oxides surfaces exhibited higher numbers of attached bacteria.
In addition, in a recent study [85], the antibacterial effects of TiO2 nanotubes could be attributed to the
oxidative stress induced as well as geometrical characteristics.
Table 1 provides a synthetic reference on the different types of biological effects that have been
reviewed in this section, with proper references.
Table 1. Biological effects.
Drug Releasing Surface Modifications In Vitro Evidence In Vivo Evidence
Enhancing bone quality
Bisphosphonates [78,79];
BMP-2 [80];
FGF-2 [81];
siRNA nanoparticles [82]
Strontium [36,77]
Antimicrobial features
Silver [86,88];
antibiotic- loaded PHBV
microsphere-alginate coatings [90]
Silver [87];
Amikacin and vancomycin [89]
Structural Surface Modifications In Vitro Evidence In Vivo Evidence
Hydroxyapatite nano-HA [97,98];HA/TiO2 nanocomposite [112]
Mineral substituted hydroxyapatite and
carbon nano tube [110]
Nanostructured surface modifications
TiO2 nanorods [117];
ribbonlike octacalcium in vitro [118];
amino-terminated films (PPAAm, PPEDA
and PSN) [59];
PPEDA [60];
PPAAm [61,62];
PPAAm and PPAAc [69];
PPAAc, PPAAm and PPAAl films [72];
PCL and PDDLLA [71];
TiN [122];
porous tantalum [123]
Ti-24 Nb-4 Zr-7.9 Sn [119];
Calcium [120]
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4. Conclusions
The most important surface modifications for the improvement of titanium dental implants
performance have been reviewed, focusing on the treatments that may develop into novel, sophisticated
next generation surfaces that are not only based on tuning roughness and wettability features. Such
technologies include inorganic and organic coatings, and will likely be capable of inducing more
actively the biological effects desired. Surface modifications have high potential for the improvement
of the Ti implant performances, such as the acceleration of osseointegration even in poor quality
bone, the protection from chemical corrosion exerted by body fluids, and the reduction of bacterial
adhesion. However, further research is required to achieve clinical evidence, at the moment still
lacking, supporting the use of the most promising surface modifications.
Acknowledgments: This work was partially funded by the Piedmont Region (PAR FSC 2007/13, “Interventi di
sostegno per la realizzazione dei poli di innovazione”, project name “FACE”, project number FA 264-204).
Author Contributions: Pietro Mandracci contributed to conception, drafted and critically revised the manuscript;
Federico Mussano and Paola Rivolo drafted and critically revised the manuscript. Stefano Carossa critically revised
the manuscript. All authors gave final approval and agree to accountable for all aspects of the present work.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Albrektsson, T.; Sennerby, L. State of the art in oral implants. J. Clin. Periodontol. 1991, 18, 474–481. [CrossRef]
[PubMed]
2. Schnitman, P.A., Shulman, L.B., Eds.; Dental implants: Benefit and risk. In Proceedings of An NIH-Harvard
Consensus Development Conference, Cambridge, MA, USA, 13–14 June 1978; U.S. Department of Health
and Human Services: Bethesda, MD, USA, 1980; pp. 1–351.
3. Zarb, G.A.; Smith, D.C.; Levant, H.C.; Graham, B.S.; Staatsexamen, W.Z. The effects of cemented and
uncemented endosseous implants. J. Prosthet. Dent. 1979, 42, 202–210. [CrossRef]
4. Cochran, D.L.; Schenk, R.K.; Lussi, A.; Higginbottom, F.L.; Buser, D. Bone response to unloaded and loaded
titanium implants with a sandblasted and acid-etched surface: A histometric study in the canine mandible.
J. Biomed. Mater. Res. 1998, 40, 1–11. [CrossRef]
5. Wennerberg, A.; Hallgren, C.; Johansson, C.; Danelli, S. A histomorphometric evaluation of screw-shaped
implants each prepared with two surface roughnesses. Clin. Oral Implants Res. 1998, 9, 11–19. [CrossRef]
[PubMed]
6. Duraccio, D.; Mussano, F.; Faga, M.G. Biomaterials for dental implants: Current and future trends.
J. Mater. Sci. 2015, 50, 4779–4812. [CrossRef]
7. Atieh, M.A.; Alsabeeha, N.H.M.; Faggion, C.M., Jr.; Duncan, W.J. The frequency of peri-implant diseases: A
systematic review and meta-analysis. J. Periodontol. 2013, 84, 1586–1598. [CrossRef] [PubMed]
8. Uskokovic´, V. When 1 + 1 > 2: Nanostructured composites for hard tissue engineering applications.
Mater. Sci. Eng. C 2015, 57, 434–451. [CrossRef] [PubMed]
9. Schweikl, H.; Müller, R.; Englert, C.; Hiller, K.-A.; Kujat, R.; Nerlich, M.; Schmalz, G. Proliferation of
osteoblasts and fibroblasts on model surfaces of varying roughness and surface chemistry. J. Mater. Sci.
Mater. Med. 2007, 18, 1895–1905. [CrossRef] [PubMed]
10. Iwaya, Y.; Machigashira, M.; Kanbara, K.; Miyamoto, M.; Noguchi, K.; Izumi, Y.; Ban, S. Surface properties
and biocompatibility of acid-etched titanium. Dent. Mater. J. 2008, 27, 415–421. [CrossRef] [PubMed]
11. Yang, G.-L.; He, F.-M.; Yang, X.-F.; Wang, X.-X.; Zhao, S.-F. Bone responses to titanium implants
surface-roughened by sandblasted and double etched treatments in a rabbit model. Oral Surg. Oral Med.
Oral Pathol. Oral Radiol. Endod. 2008, 106, 516–524. [CrossRef] [PubMed]
12. Kim, H.; Choi, S.H.; Ryu, J.J.; Koh, S.Y.; Park, J.H.; Lee, I.S. The biocompatibility of SLA-treated titanium
implants. Biomed. Mater. 2008, 3. [CrossRef] [PubMed]
13. Park, J.-W.; Jang, I.-S.; Sun, J.-Y. Bone response to endosseous titanium implants surface-modified by blasting
and chemical treatment: A histomorphometric study in the rabbit femur. J. Biomed. Mater. Res. Part B
Appl. Biomater. 2008, 84, 400–407. [CrossRef] [PubMed]
Coatings 2016, 6, 7 17 of 22
14. Bacchelli, B.; Giavaresi, G.; Franchia, M.; Martinia, D.; de Pasqualea, V.; Trirèa, A.; Fini, M.; Giardino, R.;
Ruggeri, A. Influence of a zirconia sandblasting treated surface on peri-implant bone healing: An
experimental study in sheep. Acta Biomater. 2009, 5, 2246–2257. [CrossRef] [PubMed]
15. Guo, C.Y.; Matinlinna, J.P.; Tsoi, J.K.-H.; Tang, H.A.T. Residual contaminations of silicon-based glass, alumina
and aluminum grits on a titanium surface after sandblasting. Silicon 2015. In press.
16. Rupp, F.; Scheideler, L.; Olshanska, N.; de Wild, M.; Wieland, M.; Geis-Gerstorfer, J. Enhancing surface free
energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces.
J. Biomed. Mater. Res. Part A 2006, 76A, 323–334. [CrossRef] [PubMed]
17. Le Guéhennec, L.; Soueidan, A.; Layrolle, P.; Amouriq, Y. Surface treatments of titanium dental implants for
rapid osseointegration. Dent. Mater. 2007, 23, 844–854. [CrossRef] [PubMed]
18. Buser, D.; Schenk, R.K.; Steinemann, S.; Fiorellini, J.P.; Fox, C.H.; Stich, H. Influence of surface characteristics
on bone integration of titanium implants. A histomorphometric study in miniature pigs. J. Biomed. Mater. Res.
1991, 25, 889–902. [CrossRef] [PubMed]
19. Szmukler-Moncler, S.; Perrin, D.; Ahossi, V.; Magnin, G.; Bernard, J.P. Biological properties of acid etched
titanium implants: Effect of sandblasting on bone anchorage. J. Biomed. Mater. Res. Part B Appl. Biomater.
2003, 68B, 149–159. [CrossRef] [PubMed]
20. Roach, M.D.; Williamson, R.S.; Blakely, I.P.; Didier, L.M. Tuning anatase and rutile phase ratios and nanoscale
surface features by anodization processing onto titanium substrate surfaces. Mater. Sci. Eng. C 2015, 58,
213–223. [CrossRef] [PubMed]
21. Wanga, Y.; Yub, H.; Chena, C.; Zhaoa, Z. Review of the biocompatibility of micro-arc oxidation coated
titanium alloys. Mater. Des. 2015, 85, 640–652. [CrossRef]
22. Gao, Y.-k. Surface modification of TA2 pure titanium by low energy high current pulsed electron beam
treatments. Appl. Surf. Sci. 2011, 257, 7455–7460. [CrossRef]
23. Surmeneva, M.A.; Surmenev, R.A.; Tyurin, A.I.; Mukhametkaliyev, T.M.; Teresovd, A.D.; Koval, N.N.;
Pirozhkova, T.S.; Shuvarin, I.A.; Oehr, C. Comparative study of the radio-frequency magnetron sputter
deposited CaP films fabricated onto acid-etched or pulsed electron beam-treated titanium. Thin Solid Films
2014, 571, 218–224. [CrossRef]
24. Tian, Y.S.; Chen, C.Z.; Li, S.T.; Huo, Q.H. Research progress on laser surface modification of titanium alloys.
Appl. Surf. Sci. 2005, 242, 177–184. [CrossRef]
25. Braga, F.J.C.; Marques, R.F.C.; de A. Filho, E.; Guastaldi, A.C. Surface modification of Ti dental implants by
Nd:YVO4 laser irradiation. Appl. Surf. Sci. 2007, 253, 9203–9208. [CrossRef]
26. Brånemark, R.; Emanuelsson, L.; Palmquist, A.; Thomsen, P. Bone response to laser-induced micro- and
nano-size titanium surface features. Nanomedicine 2011, 7, 220–227. [CrossRef] [PubMed]
27. Györgyey, Á.; Ungvári, K.; Kecskeméti, G.; Kopniczky, J.; Hopp, B.; Oszkó, A.; Pelsöczi, I.; Rakonczay, Z.;
Nagy, K.; Turzó, K. Attachment and proliferation of human osteoblast-like cells (MG-63) on laser-ablated
titanium implant material. Mater. Sci. Eng. C 2013, 33, 4251–4259. [CrossRef] [PubMed]
28. Cha, S.; Park, Y.-S. Plasma in dentistry. Clin. Plasma Med. 2014, 2, 4–10. [CrossRef]
29. Kim, J.-H.; Lee, M.-A.; Han, G.-J.; Cho, B.-H. Plasma in dentistry: A review of basic concepts and applications
in dentistry. Acta Odontol. Scand. 2014, 72, 1–12. [CrossRef] [PubMed]
30. Coelho, P.G.; Giro, G.; Teixeira, H.S.; Marin, C.; Witek, L.; Thompson, V.P.; Tovar, N.; Silva, N.R.F.A.
Argon-based atmospheric pressure plasma enhances early bone response to rough titanium surfaces.
J. Biomed. Mater. Res. Part A 2012, 100A, 1901–1906. [CrossRef] [PubMed]
31. Lee, J.-H.; Kim, Y.-H.; Choi, E.-H.; Kim, K.-M.; Kim, K.-N. Air atmospheric-pressure plasma-jet treatment
enhances the attachment of human gingival fibroblasts for early peri-implant soft tissue seals on titanium
dental implant abutments. Acta Odontol. Scand. 2015, 73, 67–75. [CrossRef] [PubMed]
32. Yoo, E.-M.; Uhm, S.-H.; Kwon, J.-S.; Choi, H.-S.; Choi, E.H.; Kim, K.-M.; Kim, K.-N. The study on inhibition
of planktonic bacterial growth by non-thermal atmospheric pressure plasma jet treated surfaces for dental
application. J. Biomed. Nanotechnol. 2015, 11, 334–341. [CrossRef] [PubMed]
33. Yang, C.-H.; Li, Y.-C.; Tsai, W.-F.; Ai, C.-F.; Huang, H.-H. Oxygen plasma immersion ion implantation
treatment enhances the human bone marrow mesenchymal stem cells responses to titanium surface for
dental implant application. Clin. Oral Implants Res. 2015, 26, 166–175. [CrossRef] [PubMed]
Coatings 2016, 6, 7 18 of 22
34. Ferraz, E.P.; Sa, J.C.; de Oliveira, P.T.; Alves, C., Jr.; Beloti, M.M.; Rosa, A.L. The effect of plasma-nitrided
titanium surfaces on osteoblastic cell adhesion, proliferation, and differentiation. J. Biomed. Mater. Res. Part A
2014, 102A, 991–998. [CrossRef] [PubMed]
35. Liu, C.; Zhang, Y.; Wang, L.; Zhang, X.; Chen, Q.; Wu, B. A strontium-modified titanium surface produced
by a new method and its biocompatibility. PLoS ONE 2015, 10. [CrossRef] [PubMed]
36. Wen, J.; Li, J.; Pan, H.; Zhang, W.; Zeng, D.; Xu, L.; Wu, Q.; Zhang, X.; Liu, X.; Jiang, X. Strontium delivery on
topographical titanium to enhance bioactivity and osseointegration in osteoporotic rats. J. Mater. Chem. B
2015, 3, 4790–4804. [CrossRef]
37. Surmenev, R.A. A review of plasma-assisted methods for calcium phosphate-based coatings fabrication.
Surf. Coat. Technol. 2012, 206, 2035–2056. [CrossRef]
38. Xie, C.; Lu, H.; Li, W.; Chen, F.-M.; Zhao, Y.-M. The use of calcium phosphate-based biomaterials in implant
dentistry. J. Mater. Sci. Mater. Med. 2012, 23, 853–862. [CrossRef] [PubMed]
39. Capuccini, C.; Torricelli, P.; Sima, F.; Boanini, E.; Ristoscu, C.; Bracci, B.; Socol, G.; Fini, M.; Mihailescu, I.N.;
Bigi, A. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: In vitro
osteoblast and osteoclast response. Acta Biomater. 2008, 4, 1885–1893. [CrossRef] [PubMed]
40. Li, Y.; Li, Q.; Zhu, S.; Luo, E.; Li, J.; Feng, G.; Liao, Y.; Hu, J. The effect of strontium-substituted hydroxyapatite
coating on implant fixation in ovariectomized rats. Biomaterials 2010, 31, 9006–9014. [CrossRef] [PubMed]
41. Almaguer-Flores, A.; Silva-Bermudez, P.; Galicia, R.; Rodil, S.E. Bacterial adhesion on amorphous and
crystalline metal oxide coatings. Mater. Sci. Eng. C 2015, 57, 88–99. [CrossRef] [PubMed]
42. Cimpean, A.; Popescu, S.; Ciofrangeanu, C.M.; Gleizes, A.N. Effects of LP-MOCVD prepared TiO2 thin films
on the in vitro behavior of gingival fibroblasts. Mater. Chem. Phys. 2011, 125, 85–492. [CrossRef]
43. Battiston, G.A. Dental implants of complex form coated by nanostructered TiO2 thin films via MOCVD.
Mater. Sci. Forum 2000, 352, 151–158. [CrossRef]
44. Zhao, X.; Wang, G.; Zheng, H.; Lu, Z.; Zhong, X.; Cheng, X.; Zreiqat, H. Delicate refinement of surface
nanotopography by adjusting TiO2 coating chemical composition for enhanced interfacial biocompatibility.
ACS Appl. Mater. Interfaces 2013, 5, 8203–8209. [CrossRef] [PubMed]
45. Song, D.-H.; Uhm, S.-H.; Kim, S.-E.; Kwon, J.-S.; Han, J.-G.; Kim, K.-N. Synthesis of titanium oxide thin films
containing antibacterial silver nanoparticles by a reactive magnetron co-sputtering system for application in
biomedical implants. Mater. Res. Bull. 2012, 47, 2994–2998. [CrossRef]
46. Mandracci, P.; Mussano, F.; Ricciardi, C.; Ceruti, P.; Pirri, F.; Carossa, S. Low temperature growth of thin
film coatings for the surface modification of dental prostheses. Surf. Coat. Technol. 2008, 202, 2477–2481.
[CrossRef]
47. Mandracci, P.; Ceruti, P.; Ricciardi, C.; Mussano, F.; Carossa, S. A-SiOx coatings grown on dental materials
by PECVD: Compositional analysis and preliminary investigation of biocompatibility improvements.
Chem. Vapor Depos. 2010, 16, 29–34. [CrossRef]
48. Gazia, R.; Mandracci, P.; Mussano, F.; Carossa, S. AlNx and a-SiOx coatings with corrosion resistance
properties for dental implants. Surf. Coat. Technol. 2011, 206, 1109–1115. [CrossRef]
49. Mandracci, P.; Mussano, F.; Ceruti, P.; Pirri, C.F.; Carossa, S. Reduction of bacterial adhesion on dental
composite resins by silicon-oxygen thin film coatings. Biomed. Mater. 2015, 10. [CrossRef] [PubMed]
50. Tsai, M.-T.; Chang, Y.-Y.; Huang, H.-L.; Hsu, J.-T.; Chen, Y.-C.; Wu, A.Y.-J. Characterization and antibacterial
performance of bioactive Ti-Zn-O coatings deposited on titanium implants. Thin Solid Films 2013, 528,
143–150. [CrossRef]
51. Annunziata, M.; Oliva, A.; Basile, M.A.; Giordano, M.; Mazzola, N.; Rizzo, A.; Lanza, A.; Guida, L. The
effects of titanium nitride-coating on the topographic and biological features of TPS implant surfaces. J. Dent.
2011, 39, 720–728. [CrossRef] [PubMed]
52. Kim, W.-G.; Choe, H.-C. Effects of TiN coating on the corrosion of nanostructured Ti–30Ta–xZr alloys for
dental implants. Appl. Surf. Sci. 2012, 258, 1929–1934. [CrossRef]
53. Zhang, Y.; Zheng, Y.; Li, Y.; Wang, L.; Bai, Y.; Zhao, Q.; Xiong, X.; Cheng, Y.; Tang, Z.; Deng, Y.; et al. Tantalum
nitride-decorated titanium with enhanced resistance to microbiologically induced corrosion and mechanical
property for dental application. PLoS ONE 2015, 10. [CrossRef] [PubMed]
54. Wu, H.; Zhang, X.; He, X.; Li, M.; Huang, X.; Hang, R.; Tang, B. Wear and corrosion resistance of anti-bacterial
Ti-Cu-N coatings on titanium implants. Appl. Surf. Sci. 2014, 317, 614–621. [CrossRef]
Coatings 2016, 6, 7 19 of 22
55. Huang, H.-L.; Chang, Y.-Y.; Lai, M.-C.; Lin, C.-R.; Lai, C.-H.; Shieh, T.-M. Antibacterial TaN-Ag coatings on
titanium dental implants. Surf. Coat. Technol. 2010, 205, 1636–1641. [CrossRef]
56. Lai, C.-H.; Chang, Y.-Y.; Huang, H.-L.; Kao, H.-Y. Characterization and antibacterial performance of
ZrCN/amorphous carbon coatings deposited on titanium implants. Thin Solid Films 2011, 520, 1525–1531.
[CrossRef]
57. Liang, Y.; Li, H.; Xu, J.; Li, X.; Qi, M.; Hu, M. Morphology, composition, and bioactivity of strontium-doped
brushite coatings deposited on titanium implants via electrochemical deposition. Int. J. Mol. Sci. 2014, 15,
9952–9962. [CrossRef] [PubMed]
58. Abbas, A.; Vivien, C.; Bocquet, B.; Guillochon, D.; Supiot, P. Preparation and multi-characterization of plasma
polymerized allylamine films. Plasma Proc. Polym. 2009, 6, 593–604. [CrossRef]
59. Finke, B.; Hempel, F.; Testrich, H.; Artemenko, A.; Rebl, H.; Kylián, O.; Meichsner, J.; Biederman, H.; Nebe, B.;
Weltmann, K.-D.; et al. Plasma processes for cell-adhesive titanium surfaces based on nitrogen-containing
coatings. Surf. Coat. Technol. 2011, 205, S520–S524. [CrossRef]
60. Testrich, H.; Rebl, H.; Finke, B.; Hempel, F.; Nebe, B.; Meichsner, J. Aging effects of plasma polymerized
ethylenediamine (PPEDA) thin films on cell-adhesive implant coatings. Mater. Sci. Eng. C 2013, 33, 3875–3880.
[CrossRef] [PubMed]
61. Seo, H.S.; Kim, B.H.; Ko, Y.M. Fabrication of anodized titanium with immobilization of hyaluronic acid to
improve biological performance. Prog. Org. Coat. 2010, 69, 38–44. [CrossRef]
62. Heller, M.; Kämmerer, P.W.; Al-Nawas, B.; Luszpinski, M.-A.; Förch, R.; Brieger, J. The effect of extracellular
matrix proteins on the cellular response of HUVECS and HOBS after covalent immobilization onto titanium.
J. Biomed. Mater. Res. Part A 2015, 103A, 2035–2044. [CrossRef] [PubMed]
63. Ricciardi, S.; Castagna, R.; Severino, S.M.; Ferrante, I.; Frascella, F.; Celasco, E.; Mandracci, P.; Vallini, I.;
Mantero, G.; Pirri, C.F.; et al. Surface functionalization by poly-acrylic acid plasma-polymerized films for
microarray DNA diagnostics. Surf. Coat. Technol. 2012, 207, 389–399. [CrossRef]
64. Rivolo, P.; Severino, S.M.; Ricciardi, S.; Frascella, F.; Geobaldo, F. Protein immobilization on nanoporous
silicon functionalized by RF activated plasma polymerization of acrylic acid. J. Colloid Interface Sci. 2014, 416,
73–80. [CrossRef] [PubMed]
65. Nisticò, R.; Rosellini, A.; Rivolo, P.; Faga, M.G.; Lamberti, R.; Martorana, S.; Castellino, M.; Virga, A.;
Mandracci, P.; Malandrino, M.; et al. Surface functionalisation of polypropylene hernia-repair meshes by
RF-activated plasma polymerisation of acrylic acid and silvernanoparticles. Appl. Surf. Sci. 2015, 328,
287–295. [CrossRef]
66. Ko, Y.-M.; Lee, K.; Kim, B.H. Effect of functional groups on biodegradation and pre-osteoblastic cell response
on the plasma-polymerized magnesium surface. Jpn. J. Appl. Phys. 2013, 52. [CrossRef]
67. Pistillo, B.R.; Perrotta, A.; Gristina, R.; Ceccone, G.; Nardulli, M.; d’Agostino, R.; Favia, P. Water resistant
ethylene/acrylic acid plasma-deposited coatings. Surf. Coat. Technol. 2011, 205, S534–S536. [CrossRef]
68. Bazaka, K.; Jacob, M.V. Solubility and surface interactions of RF plasma polymerized polyterpenol thin films.
Mater. Express 2012, 2, 285–293.
69. Schröder, K.; Finke, B.; Ohl, A.; Lüthen, F.; Bergemann, C.; Nebe, B.; Rychly, J.; Walschus, U.; Schlosser, M.;
Liefeith, K.; et al. Capability of differently charged plasma polymer coatings for control of tissue interactions
with titanium surfaces. J. Adhes. Sci. Technol. 2010, 24, 1191–1205. [CrossRef]
70. Gurzawska, K.; Svava, R.; Yihua, Y.; Haugshøj, K.B.; Dirscherl, K.; Levery, S.B.; Byg, I.; Damager, I.;
Nielsen, M.W.; Jørgensen, B.; et al. Osteoblastic response to pectin nanocoating on titanium surfaces.
Mater. Sci. Eng. C 2014, 43, 117–125. [CrossRef] [PubMed]
71. Intranuovo, F.; Sardella, E.; Gristina, R.; Nardulli, M.; White, L.; Howard, D.; Shakesheff, K.M.;
Alexander, M.R.; Favia, P. PE-CVD processes improve cell affinity of polymer scaffolds for tissue engineering.
Surf. Coat. Technol. 2011, 205, S548–S551. [CrossRef]
72. Jung, S.-C.; Lee, K.; Kim, B.-H. Biocompatibility of plasma polymerized sandblasted large grit and acid
titanium surface. Thin Solid Films 2012, 521, 150–154. [CrossRef]
73. Kim, B.H.; Myung, S.W.; Jung, S.C.; Ko, Y.-M. Plasma surface modification for immobilization of bone
morphogenic protein-2 on polycaprolactone scaffolds. Jpn J. Appl. Phys. 2013, 52. [CrossRef]
74. Da Ponte, G.; Sardella, E.; Fanelli, F.; van Hoeck, A.; d’Agostino, R.; Paulussen, S.; Favia, P. Atmospheric
pressure plasma deposition of organic films of biomedical interest. Surf. Coat. Technol. 2011, 205, S525–S528.
[CrossRef]
Coatings 2016, 6, 7 20 of 22
75. Bazaka, K; Jacob, M.V. Synthesis of radio frequency plasma polymerized non-synthetic Terpinen-4-ol thin
films. Mater. Lett. 2009, 63, 1594–1597. [CrossRef]
76. Bilezikian, J.P.; Raisz, L.G.; Martin, T.J. Principles of Bone Biology, 3rd ed.; Academic Press: San Diego, CA,
USA, 2008.
77. Li, Y.; Qi, Y.; Gao, Q.; Niu, Q.; Shen, M.; Fu, Q.; Hu, K.; Kong, L. Effects of a micro/nano rough
strontium-loaded surface on osseointegration. Int. J. Nanomed. 2015, 10, 4549–4563.
78. Bosco, R.; Iafisco, M.; Tampieri, A.; Jansen, J.A.; Leeuwenburgh, S.C.G.; van den Beucken, J.J.J.P.
Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant
coatings to decrease osteoclastic activity. Appl. Surf. Sci. 2015, 328, 516–524. [CrossRef]
79. Boanini, E.; Torricelli, P.; Sima, F.; Axente, E.; Fini, M.; Mihailescu, I.N.; Bigi, A. Strontium and zoledronate
hydroxyapatites graded composite coatings for bone prostheses. J. Colloid Interface Sci. 2015, 448, 1–7.
[CrossRef] [PubMed]
80. Wang, Z.; Li, C.; Xu, J.; Wang, K.; Lu, X.; Zhang, H.; Qu, S.; Zhen, G.; Ren, F. Bioadhesive microporous
architectures by self-assembling polydopamine microcapsules for biomedical applications. Chem. Mater.
2015, 27, 848–856. [CrossRef]
81. Kumorek, M.; Kubies, D.; Filová, E.; Houska, M.; Kasoju, N.; Chánová, E.M.; Mateˇjka, R.; Krýslová, M.;
Bacˇáková, L.; Rypácˇek, F. Cellular responses modulated by FGF-2 adsorbed on albumin/heparin
layer-by-layer assemblies. PLoS ONE 2015, 10. [CrossRef] [PubMed]
82. Song, W.; Song, X.; Yang, C.; Gao, S.; Klausen, L.H.; Zhang, Y.; Dong, M.; Kjems, J. Chitosan/siRNA
functionalized titanium surface via a layer-by-layer approach for in vitro sustained gene silencing and
osteogenic promotion. Int. J. Nanomed. 2015, 10, 2335–2346.
83. Losic, D.; Aw, M.S.; Santos, A.; Gulati, K.; Bariana, M. Titania nanotube arrays for local drug delivery: Recent
advances and perspectives. Expert Opin. Drug Deliv. 2015, 12, 103–127. [CrossRef] [PubMed]
84. Hamlekhan, A.; Sinha-Ray, S.; Takoudis, C.; Mathew, M.T.; Sukotjo, C.; Yarin, A.L.; Shokuhfar, T. Fabrication
of drug eluting implants: Study of drug release mechanism from titanium dioxide nanotubes. J. Phys. D
Appl. Phys. 2015, 48. [CrossRef]
85. Shi, X.; Xu, Q.; Tian, A.; Tian, Y.; Xue, X.; Sun, H.; Yang, H.; Dong, C. Antibacterial activities of TiO2 nanotubes
on Porphyromonas gingivalis. RSC Adv. 2015, 5, 34237–34242. [CrossRef]
86. Liu, X.-Q.; Chen, Q.-D.; Wang, R.; Wang, L.; Yu, X.-L.; Cao, J.-N.; Zhou, Y.-M.; Sun, H.-B. Simultaneous
femtosecond laser doping and surface texturing for implanting applications. Adv. Mater. Interfaces 2015, 2.
[CrossRef]
87. Qin, H.; Cao, H.; Zhao, Y.; Jin, G.; Cheng, M.; Wang, J.; Jiang, Y.; An, Z.; Zhang, X.; Liu, X. Antimicrobial and
osteogenic properties of silver-ion-implanted stainless steel. ACS Appl. Mater. Interfaces 2015, 7, 10785–10794.
[CrossRef] [PubMed]
88. Unosson, E.; Rodriguez, D.; Welch, K.; Engqvist, H. Reactive combinatorial synthesis and characterization of
a gradient Ag-Ti oxide thin film with antibacterial properties. Acta Biomater. 2015, 11, 503–510. [CrossRef]
[PubMed]
89. Jennings, J.A.; Carpenter, D.P.; Troxel, K.S.; Beenken, K.E.; Smeltzer, M.S.; Courtney, H.S.; Haggard, W.O.
Novel antibiotic-loaded point-of-care implant coating inhibits biofilm. Clin. Orthop. Relat. Res. 2015, 473,
2270–2282. [CrossRef] [PubMed]
90. Chen, Q.; Li, W.; Goudouri, O.-M.; Ding, Y.; Cabanas-Polo, S.; Boccaccini, A.R. Electrophoretic deposition
of antibiotic loaded PHBV microsphere-alginate composite coating with controlled delivery potential.
Colloids Surf. B Biointerfaces 2015, 130, 199–206. [CrossRef] [PubMed]
91. Bloemers, F.W.; Blokhuis, T.J.; Patka, P.; Bakker, F.C.; Wippermann, B.W.; Haarman, H.J.Th.M. Autologous
bone versus calcium-phosphate ceramics in treatment of experimental bone defects. J. Biomed. Mater. Res. B
Appl. Biomater. 2003, 66, 526–531. [CrossRef] [PubMed]
92. Zeitler, T.; Cormack, A. Interaction of water with bioactive glass surfaces. J. Cryst. Growth 2006, 294, 96–102.
[CrossRef]
93. Pereira, M.; Jones, J.; Hench, L. Bioactive glass and hybrid scaffolds prepared by sol-gel. Adv. Appl. Ceram.
2005, 104, 35–42. [CrossRef]
94. LeGeros, R. Calcium phosphate-based osteoinductive materials. Chem. Rev. 2008, 108, 4742–4753. [CrossRef]
[PubMed]
Coatings 2016, 6, 7 21 of 22
95. Kandori, K.; Fudo, A.; Ishikawa, T. Surface structure and properties of fluoridated calcium hydroxyapatite.
Colloids Surf. B 2002, 24, 145–149. [CrossRef]
96. Robinson, R.A. An electron microscope study of the crystalline inorganic components of bone and its
relationship to the organic matrix. J. Bone Joint Surg. 1952, 34A, 389–434. [PubMed]
97. Webster, T.J.; Siegel, R.; Bizios, R. Osteoblast adhesion on nanophase ceramics. Biomaterials 1999, 20,
1221–1227. [CrossRef]
98. Webster, T.J.; Ergun, C.; Doremus, R.H.; Siegel, R.W.; Bizios, R. Enhanced functions of osteoblasts on
nanophase ceramics. Biomaterials 2000, 21, 1803–1810. [CrossRef]
99. Rinnerthaler, S.; Roschger, P.; Jakob, F.; Nader, K.; Klaushofer, P.F. Scanning small angle X-ray scattering
analysis of human bone sections. Calcif. Tissue Int. 1999, 64, 422–426. [CrossRef] [PubMed]
100. Žižak, I.; Paris, O.; Roshger, P.; Bernstorff, S.; Amenitsch, H.; Klaushofer, K.; Fratzl, P. Investigation of bone
and cartilage by synchrotron scanning-SAXS and -WAXD with micrometer spatial resolution. J. Appl. Cryst.
2000, 33, 820–823.
101. Celotti, G.; Tampieri, A.; Sprio, S.; Landi, E.; Bertinetti, L.; Martra, G.; Ducati, C. Crystallinity in apatites:
How can a truly disordered fraction be distinguished from nanosize crystalline domains? J. Mater. Sci.
Mater. Med. 2006, 17, 1079–1087. [CrossRef] [PubMed]
102. Isobe, T.; Nakamura, S.; Nemoto, R.; Senna, M. Solid-state double nuclear magnetic resonance study of
the local structure of calcium phosphate nanoparticles synthesized by a wet-mechanochemical reaction.
J. Phys. Chem. B 2002, 106, 5169–5176. [CrossRef]
103. Cazalbou, S.; Combes, C.; Eichert, D.; Rey, C. Adaptative physico-chemistry of bio-related calcium
phosphates. J. Mater. Chem. 2004, 14, 2148–2153. [CrossRef]
104. Jaeger, C.; Welzel, T.; Meyer-Zaika, W.; Epple, M. A solid-state NMR investigation of the structure of
nanocrystalline hydroxyapatite. Magn. Reson. Chem. 2006, 44, 573–580. [CrossRef] [PubMed]
105. Bertinetti, L.; Tampieri, A.; Landi, E.; Ducati, C.; Midgley, P.A.; Coluccia, S.; Martra, G. Surface structure,
hydration, and cationic sites of nanohydroxyapatite: UHR-TEM, IR, and microgravimetric studies.
J. Phys. Chem. C 2007, 111, 4027–4035. [CrossRef]
106. Sakhno, Y.; Bertinetti, L.; Iafisco, M.; Tanmieri, A.; Roveri, N.; Martra, G. Surface hydration and cationic sites
of nanohydroxyapatites with amorphous or cristalline surfaces: A comparative study. J. Phys. Chem. C 2010,
114, 16640–16648. [CrossRef]
107. Bertinetti, L.; Drouet, C.; Combes, C.; Rey, C.; Tampieri, A.; Coluccia, S.; Martra, G. Surface characteristics of
nanocrystalline apatites: Effect of Mg surface enrichment on morphology, surface hydration species, and
cationic environments. Langmuir 2009, 25, 5647–5654. [CrossRef] [PubMed]
108. Kasemo, B. Biological surface science. Surf. Sci. 2002, 500, 656–677. [CrossRef]
109. Guo, Y.-P.; Guan, J.-J.; Yang, J.; Wang, Y.; Zhang, C.-Q.; Ke, Q.-F. Hybrid nanostructured
hydroxyapatite-chitosan composite scaffold: Bioinspired fabrication, mechanical properties and biological
properties. J. Mater. Chem. B 2015, 3, 4679–4689. [CrossRef]
110. Gopi, D.; Shinyjoy, E.; Karthika, A.; Nithiya, S.; Kavitha, L.; Rajeswari, D.; Tang, T. Single walled
carbon nanotubes reinforced mineralized hydroxyapatite composite coatings on titanium for improved
biocompatible implant applications. RSC Adv. 2015, 5, 36766–36778. [CrossRef]
111. Lai, H.-C.; Tsai, H.-H.; Hung, K.-Y.; Feng, H.-P. Fabrication of hydroxyapatite targets in radio frequency
sputtering for surface modification of titanium dental implants. J. Int. Mater. Sys. Struct. 2015, 26, 1050–1058.
[CrossRef]
112. Farnoush, H.; Aldiç, G.; Çimenog˘lu, H. Functionally graded HA-TiO2 nanostructured composite coating on
Ti-6Al-4V substrate via electrophoretic deposition. Surf. Coat. Technol. 2015, 265, 7–15. [CrossRef]
113. Surmeneva, M.A.; Kleinhans, C.; Vacun, G.; Kluger, P.J.; Schönhaar, V.; Müller, M.; Hein, S.B.; Wittmar, A.;
Ulbricht, M.; Prymak, O.; et al. Nano-hydroxyapatite-coated metal-ceramic composite of iron-tricalcium
phosphate: Improving the surface wettability, adhesion and proliferation of mesenchymal stem cells in vitro.
Colloids Surf. B Biointerfaces 2015, 135, 386–393. [CrossRef] [PubMed]
114. Zhang, H.; Fu, Q.-W.; Sun, T.-W.; Chen, F.; Qi, C.; Wu, J.; Cai, Z.-Y.; Qian, Q.-R.; Zhu, Y.-J. Amorphous calcium
phosphate, hydroxyapatite and poly(D,L-lactic acid) composite nanofibers: Electrospinning preparation,
mineralization and in vivo bone defect repair. Colloids Surf. B Biointerfaces 2015, 136, 27–36. [CrossRef]
[PubMed]
Coatings 2016, 6, 7 22 of 22
115. Kulkarni, M.; Mazare, A.; Gongadze, E.; Perutkova, Š.; Kralj-Iglic, V.; Milošev, I.; Schmuki, P.; Iglicˇ, A.;
Mozeticˇ, M. Titanium nanostructures for biomedical applications. Nanotechnology 2015, 26. [CrossRef]
[PubMed]
116. Shen, X.; Ma, P.; Hu, Y.; Xu, G.; Zhou, J.; Cai, K. Mesenchymal stem cell growth behavior on micro/nano
hierarchical surfaces of titanium substrates. Colloids Surf. B Biointerfaces 2015, 127, 221–232. [CrossRef]
[PubMed]
117. Cheng, K.; Yu, M.; Liu, Y.; Ge, F.; Lin, J.; Weng, W.; Wang, H. Influence of integration of TiO2 nanorods into
its nanodot films on pre-osteoblast cell responses. Colloids Surf.B Biointerfaces 2015, 126, 387–393. [CrossRef]
[PubMed]
118. Jiang, P.; Liang, J.; Song, R.; Zhang, Y.; Ren, L.; Zhang, L.; Tang, P.; Lin, C. Effect
of octacalcium-phosphate-modified micro/nanostructured titania surfaces on osteoblast response.
ACS Appl. Mater. Interfaces 2015, 7, 14384–14396. [CrossRef] [PubMed]
119. Liu, X.H.; Wu, L.; Ai, H.J.; Han, Y.; Hu, Y. Cytocompatibility and early osseointegration of nanoTiO2-modified
Ti-24 Nb-4 Zr-7.9 Sn surfaces. Mater. Sci. Eng. C 2015, 48, 256–262. [CrossRef] [PubMed]
120. Anitua, E.; Piñas, L.; Murias, A.; Prado, R.; Tejero, R. Effects of calcium ions on titanium surfaces for bone
regeneration. Colloids Surf. B Biointerfaces 2015, 130, 173–181. [CrossRef] [PubMed]
121. Vallée, A.; Faga, M.G.; Mussano, F.; Catalano, F.; Tolosano, E.; Carossa, S.; Altruda, F.; Martra, G.
Alumina-zirconia composites functionalized with laminin-1 and laminin-5 for dentistry: Effect of protein
adsorption on cellular response. Colloids Surf B Biointerfaces 2014, 114, 284–293. [CrossRef] [PubMed]
122. Shi, X.; Xu, L.; Munar, M.L.; Ishikawa, K. Hydrothermal treatment for TiN as abrasion resistant dental
implant coating and its fibroblast response. Mater. Sci. Eng. C 2015, 49, 1–6. [CrossRef] [PubMed]
123. Liu, Y.; Bao, C.; Wismeijer, D.; Wu, G. The physicochemical/biological properties of porous tantalum and
the potential surface modification techniques to improve its clinical application in dental implantology.
Mater. Sci. Eng. C 2015, 49, 323–329. [CrossRef] [PubMed]
124. Almeida Alves, C.F.; Cavaleiro, A.; Carvalho, S. Bioactivity response of Ta1´xOx coatings deposited by
reactive DC magnetron sputtering. Mater. Sci. Eng. C 2016, 58, 110–118. [CrossRef] [PubMed]
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons by Attribution
(CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
